Answers are grounded in this paper and cite their sources.
Evaluates efficacy and safety of cenobamate in tumor-related epilepsy, suggesting potential benefits for treatment.
To evaluate the efficacy and safety of cenobamate as adjunctive therapy in patients with tumor-related epilepsy (TRE).
No takes yet. Share an insight, caveat, or question.
Safa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: